https://www.profitconfidential.com/marijuana/marijuana-stocks/green-light-marijuana-market-move-higher/
Green Light for Marijuana Market to Move Higher
George Leong, B.Comm.
Profit Confidential
2018-06-29T07:00:59Z
2018-07-06 14:57:32 Emerald Health TherapeuticsEmerald HealthOTCMKTS:EMHTFAurora CannabisOTCMKTS:ACBFFCanada recently gave the final green light to marijuana legalization, which will be in place on October 17. The North American market could reach $47 billion by 2027. Two stocks that are worth a look are Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) and Aurora Cannabis Inc (OTCMKTS:ACBFF).
Marijuana Stocks
https://www.profitconfidential.com/wp-content/uploads/2018/06/marijuana-market-bull-300x200.jpg
[caption id="attachment_129973" align="alignleft" width="300"]iStock.com/sintendo[/caption]

The Move to Legalize Marijuana Could Take Off

Circle October 17 on your calendar, because that will be the day that Canada becomes the first western country to legalize marijuana for recreational use.
The Canadian situation will be closely monitored by countries around the world that are also looking to legalize recreational marijuana.
If things in Canada go as well as many expect, pundits predict that the wave could spread to Europe and the United States, where nine states and the District of Columbia have already legalized marijuana. California is the biggest legal marijuana market in the country.
There is really no consensus on how large the legal marijuana market can grow, but the general feeling is that the adoption of recreational marijuana will take a big chunk from the unregulated marijuana business carried out on street corners and alleyways.
Researchers estimate that the North American legal marijuana market could surge to around $47.3 billion by 2027, up from $9.2 billion in 2017. The global market could reach $57.0 billion. ("Legal Cannabis Industry Poised For Big Growth, In North America And Around The World," Forbes, March 1, 2018)
Those numbers could be conservative, depending on how many other countries decide to legalize marijuana.

Two Marijuana Stocks to Watch

On the smaller end, an intriguing marijuana play is Emerald Health Therapeutics Inc (OTCMKTS:EMHTF, CVE:EMH), which has a market cap of $410.5 million.
Emerald Health Therapeutics is approved to produce marijuana in Canada, which is a key step to becoming a key player in the sale of marijuana.
The company is currently developing a 1.1-million-square-foot greenhouse to grow marijuana in a 50/50 venture with Village Farms International Inc (OTCMKTS:VFFIF, TSE:VFF) in British Columbia.
Once completed, the facility will have an annual capacity of 165,000 pounds of marijuana. That’s a lot of weed.
Emerald Health Therapeutics is also constructing a 500,000-square-foot hybrid indoor and greenhouse marijuana facility in Vancouver and is in the process of retrofitting a 75,000-square-foot facility in Quebec that is estimated to be able to farm 22,000 pounds per year.
Chart courtesy of StockCharts.com
If you are looking for a bigger marijuana producer, a good fit could be mid-cap Aurora Cannabis Inc (OTCMKTS:ACBFF, TSE:ACB), with a market cap of almost $4.1 billion.
Aurora Cannabis has been a consolidator in the marijuana space and is in the process of acquiring MedReleaf Corp (OTCMKTS:MEDFF, TSE:LEAF) in a CA$3.2-billion deal.
Chart courtesy of StockCharts.com
Aurora Cannabis currently has over 2.0 million square feet of growing facility, not including the addition of MedReleaf.
At full production, Aurora Cannabis will produce more than 530,000 pounds of high-grade marijuana annually.
In addition to the Canadian market, Aurora Cannabis has ventures in Germany, Denmark, Italy, and Australia.

Analyst Take

Aurora Cannabis is much further along and is a bigger player than many companies in the legal marijuana sector. That's why it is one of the top picks.
Emerald Health Therapeutics is more of an emerging company and offers a higher risk-to-reward opportunity.
Including both stocks in an investment portfolio would spread out the risk.

Green Light for Marijuana Market to Move Higher

The Move to Legalize Marijuana Could Take Off

Circle October 17 on your calendar, because that will be the day that Canada becomes the first western country to legalize marijuana for recreational use.

The Canadian situation will be closely monitored by countries around the world that are also looking to legalize recreational marijuana.

If things in Canada go as well as many expect, pundits predict that the wave could spread to Europe and the United States, where nine states and the District of Columbia have already legalized marijuana. California is the biggest legal marijuana market in the country.

There is really no consensus on how large the legal marijuana market can grow, but the general feeling is that the adoption of recreational marijuana will take a big chunk from the unregulated marijuana business carried out on street corners and alleyways.

Those numbers could be conservative, depending on how many other countries decide to legalize marijuana.

Two Marijuana Stocks to Watch

On the smaller end, an intriguing marijuana play is Emerald Health Therapeutics Inc (OTCMKTS:EMHTF, CVE:EMH), which has a market cap of $410.5 million.

Emerald Health Therapeutics is approved to produce marijuana in Canada, which is a key step to becoming a key player in the sale of marijuana.

The company is currently developing a 1.1-million-square-foot greenhouse to grow marijuana in a 50/50 venture with Village Farms International Inc (OTCMKTS:VFFIF, TSE:VFF) in British Columbia.

Once completed, the facility will have an annual capacity of 165,000 pounds of marijuana. That’s a lot of weed.

Emerald Health Therapeutics is also constructing a 500,000-square-foot hybrid indoor and greenhouse marijuana facility in Vancouver and is in the process of retrofitting a 75,000-square-foot facility in Quebec that is estimated to be able to farm 22,000 pounds per year.

Dear Reader: There is no magic formula to getting rich. Success in investment vehicles with the best prospects for price appreciation can only be achieved through proper and rigorous research and analysis. We are 100% independent in that we are not affiliated with any bank or brokerage house. Information contained herein, while believed to be correct, is not guaranteed as accurate. Warning: Investing often involves high risks and you can lose a lot of money. Please do not invest with money you cannot afford to lose. The opinions in this content are just that, opinions of the authors. We are a publishing company and the opinions, comments, stories, reports, advertisements and articles we publish are for informational and educational purposes only; nothing herein should be considered personalized investment advice. Before you make any investment, check with your investment professional (advisor). We urge our readers to review the financial statements and prospectus of any company they are interested in. We are not responsible for any damages or losses arising from the use of any information herein. Past performance is not a guarantee of future results. All registered trademarks are the property of their respective owners.

From: Michael Lombardi, MBASubject: Gold: The Stock Contrarian Investors’ Best Play of the Decade